Ms. Ashe is a seasoned executive with over 25 years of experience in corporate and business development in the pharmaceutical and biotech industries. Ms. Ashe is currently the Chief Business Officer at the New York Genome Center, an independent, nonprofit academic research institution focused on translating genomic research into the development of new therapies for human disease. Previously, she served as Vice President of Corporate Development for Endo’s branded, generic and platform drug delivery pharmaceutical business units. Prior to that, Ms. Ashe was a Partner at GlaxoSmithKline’s corporate venture capital fund, SR One. Prior to that, Ms. Ashe led GSK’s US Corporate Legal Group supporting US-based mergers, acquisitions and equity investments. Prior to that, Ms. Ashe led GSK’s global Business Development Transactions Legal Team supporting both the pharmaceutical and consumer healthcare business units. Ms. Ashe received her BS degree in Biology from Pennsylvania State University, her law degree from Villanova University School of Law and is a registered patent attorney.